
NovelStem International Corp. Share · US67001V1098 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NovelStem International Corp.
No Price
Closing Price OTC 01.05.2026:
0,01 USD
01.05.2026 18:10
Current Prices from NovelStem International Corp.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
NSTM
|
USD
|
01.05.2026 18:10
|
0,01 USD
| 0,00 USD |
Company Profile for NovelStem International Corp. Share
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.
Company Data
Name NovelStem International Corp.
Company NovelStem International Corp.
Website
https://www.novelstem.com
Primary Exchange
UTC
ISIN US67001V1098
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Jan H. Loeb
Country United States of America
Currency USD
Employees -
Address 2255 Glades Road, 33431 Boca Raton
IPO Date 1993-11-12
Dividends from 'NovelStem International Corp.'
| Ex-Date | Dividend per Share |
|---|---|
| 02.04.2018 | 0,45 USD |
| 28.02.2018 | 0,45 USD |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | NSTM |
More Shares
Investors who hold NovelStem International Corp. also have the following shares in their portfolio:

